Showing results (601-610 of 708) with videos related to

Sort By:
Pageof 71
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
Journal of Substance Use and Addiction Treatment|May 2, 2026
A scoping review of implementation strategies to reduce stigma toward people who use substances in healthcare settingsC Cioffi, J Baloh, M Brunner, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
A novel hyperactive BCR::ABL1 e6a3 variant confers resistance to combined asciminib plus ponatinib therapyValentina Nardi, Joshua Schwieterman, Sekhu Ansari, et al.
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic SyndromesMia Y Platt, Amir T Fathi, Darrell R Borger, et al.
Nature Immunology|January 3, 2024
A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responsesTobias M Brunner, Sebastian Serve, Anna-Friederike Marx, et al.
Journal of the American Chemical Society|August 27, 2025
Bottom-up Investigation of Spatiotemporal Glycocalyx Dynamics with Interferometric Scattering MicroscopyCarla M Brunner, Lorenz Pietsch, Ingo Vom Sondern, et al.
Scientific Reports|November 3, 2019
Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinomaDenner S Dos Anjos, Cynthia Bueno, Larissa F Magalhães, et al.
Pageof 71